Uttar Pradesh, India

Pradeep S Jadhavar

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Greater Noida, IN (2020)
  • Noida, IN (2021)
  • Uttar Pradesh, IN (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Inventor Profile: Pradeep S. Jadhavar**

Introduction

Pradeep S. Jadhavar is a prolific inventor hailing from Uttar Pradesh, India. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals. His work mainly focuses on the development of compounds that serve as therapeutic agents, particularly in oncology.

Latest Patents

Among his latest innovations, Jadhavar has developed two notable patents:

1. **Heterocyclic compounds as adenosine antagonists** - This patent includes the creation of 5,6-disubstituted 2-aminopyrazine compounds that function as modulators of adenosine receptors. These compounds are promising candidates for therapeutic applications in diseases mediated by G-protein-coupled receptor signaling pathways, particularly in the field of oncology.

2. **1,8-naphthyridinone compounds and uses thereof** - This patent focuses on the introduction of 1,8-naphthyridinone compounds as modulators of adenosine receptors. Similar to his previous work, these compounds show potential as therapeutic agents for oncology-related diseases.

Career Highlights

Pradeep S. Jadhavar currently works with Nuvation Bio Inc., where he continues to push the boundaries of pharmaceutical research and development. His extensive work in creating innovative compounds has made a notable impact on the industry.

Collaborations

In his professional journey, Jadhavar collaborates with esteemed colleagues including Son Minh Pham and Farha Khan. Their combined efforts foster innovation and contribute to advancements in therapeutic strategies.

Conclusion

Pradeep S. Jadhavar exemplifies the spirit of innovation in the life sciences sector. With a focused vision on therapeutic compounds and a commitment to advancing oncology treatments, he remains a key figure in the landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…